EUVIMEDEUVIMED entdecken
Crossref

Codelivery of Methicillin and a TLR-9 Agonist Promotes Bacterial Clearance and Establishes Reinfection Protection in a Model of Methicillin-Resistant Staphylococcus aureus Renal Infection

Noah Y. Brittain, Vanessa Chan, Tien Do, Lucas J. Andrew, Alaleh Yourdkhani, Robert E. W. Hancock, Shyh-Dar Li, Joel A. Finbloom

ACS Infectious Diseases · 10.11.2026

DOI: 10.1021/acsinfecdis.6c01001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Infectious Diseases, online erschienen am 10.11.2026. Verfasst von Noah Y. Brittain und 7 weiteren Autor:innen. Die Arbeit nennt 28 Literaturangaben. Gefördert von: Canadian Institutes of Health Research, Faculty of Pharmaceutical Sciences, University of British Columbia, Natural Sciences and Engineering Research Council of Canada.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Methicillin-resistant Staphylococcus aureus (MRSA) infections represent a significant clinical challenge, with high rates of β-lactam resistance and reinfection. Here, we report a combination therapy combining methicillin with a Toll-like receptor 9 (TLR9) agonist (CpG-ODN M362) delivered via a subcutaneously injectable hyaluronic acid - methylcellulose (HAMC) hydrogel for the treatment of MRSA kidney infections. In a murine renal infection model, combination therapy achieved logarithmic reductions in renal bacterial burden compared to either monotherapy, while also preserving protective immune memory that methicillin alone failed to generate. Formulation within a thermosensitive, shear-thinning HAMC hydrogel enabled sustained codelivery of both agents from a single subcutaneous injection, enhancing bacterial clearance and humoral immune responses compared to daily bolus administration. This work demonstrates that hydrogel-mediated immunostimulatory combination therapy represents a promising single-dose strategy for treating MRSA infection with otherwise ineffective antibiotics while simultaneously guarding against reinfection.

Förderung

  • Canadian Institutes of Health Research
  • Faculty of Pharmaceutical Sciences, University of British Columbia
  • Natural Sciences and Engineering Research Council of Canada
  • Michael Smith Health Research BC
  • University of British Columbia

Zitieren

APA

Brittain, N. Y., Chan, V., Do, T., Andrew, L. J., Yourdkhani, A., Hancock, R. E. W., Li, S., & Finbloom, J. A. (2026). Codelivery of Methicillin and a TLR-9 Agonist Promotes Bacterial Clearance and Establishes Reinfection Protection in a Model of Methicillin-Resistant Staphylococcus aureus Renal Infection. ACS Infectious Diseases. https://doi.org/10.1021/acsinfecdis.6c01001

Vancouver

Brittain NY, Chan V, Do T, Andrew LJ, Yourdkhani A, Hancock REW, et al. Codelivery of Methicillin and a TLR-9 Agonist Promotes Bacterial Clearance and Establishes Reinfection Protection in a Model of Methicillin-Resistant Staphylococcus aureus Renal Infection. ACS Infectious Diseases. 2026. doi:10.1021/acsinfecdis.6c01001

BibTeX
@article{Brittain2026,
  author = {Brittain, Noah Y. and Chan, Vanessa and Do, Tien and Andrew, Lucas J. and Yourdkhani, Alaleh and Hancock, Robert E. W. and Li, Shyh-Dar and Finbloom, Joel A.},
  title = {Codelivery of Methicillin and a TLR-9 Agonist Promotes Bacterial Clearance and Establishes Reinfection Protection in a Model of Methicillin-Resistant Staphylococcus aureus Renal Infection},
  journal = {ACS Infectious Diseases},
  year = {2026},
  doi = {10.1021/acsinfecdis.6c01001}
}
Kostenlos starten →